cbdMD (YCBD) Cash & Equivalents (2016 - 2025)

cbdMD has disclosed Cash & Equivalents across 10 years of filings, most recently posting $3.4 million for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $3.4 million, up 71.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (up 71.96% YoY), and the FY2025 annual result was $2.3 million, down 7.8% from the prior year.
• Cash & Equivalents came in at $3.4 million for Q4 2025 at cbdMD, up from $2.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $26.4 million in Q3 2021 to a low of $1.1 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $2.6 million (2023), against an average of $7.4 million.
• Across the five-year window, Cash & Equivalents soared 78.16% in 2021 and tumbled 87.11% in 2023, its largest moves.
• cbdMD's Cash & Equivalents stood at $19.7 million in 2021, then slumped by 82.98% to $3.4 million in 2022, then plunged by 55.11% to $1.5 million in 2023, then jumped by 30.92% to $2.0 million in 2024, then jumped by 71.96% to $3.4 million in 2025.
• The last three Cash & Equivalents figures came in at $3.4 million (Q4 2025), $2.3 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.